A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
Status:
Completed
Trial end date:
2017-01-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and tolerability of Faslodex
(fulvestrant) with Arimidex (anastrozole) in postmenopausal women with hormone receptor
positive advanced breast cancer.